QT
Qualigen Therapeutics, Inc.
SEC filingBiotechnology · Carlsbad, CA
Amount raised$4.5Msold at filing
Total offering$4.5M
Investors in the raise14count reported to the SEC
FiledAug 13, 2025first sale Jul 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Robert B. LimDirector
Braeden LichtiDirector
Kevin Richardson IIDirector
Campbell BecherExecutive Officer, Director
Cody B. PriceDirector
Executive officers, directors and promoters as listed on the Form D.